NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

$2.27
-0.02 (-0.87%)
(As of 04/22/2024 ET)
Today's Range
$2.21
$2.35
50-Day Range
$2.16
$2.61
52-Week Range
$0.85
$3.00
Volume
41,200 shs
Average Volume
96,655 shs
Market Capitalization
$436.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.80

Aveanna Healthcare MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
20.7% Downside
$1.80 Price Target
Short Interest
Bearish
2.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.07) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.08 out of 5 stars

Medical Sector

900th out of 909 stocks

Home Health Care Services Industry

8th out of 8 stocks

AVAH stock logo

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AVAH Stock Price History

AVAH Stock News Headlines

Aveanna Healthcare Holdings Inc
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Aveanna Healthcare Holdings Inc (AVAH)
Aveanna Healthcare names new Chief Legal Officer
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Q4 2023 Aveanna Healthcare Holdings Inc Earnings Call
Aveanna Healthcare Promotes Matt Buckhalter To CFO
RBC Capital Keeps Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Holdings Inc AVAH
See More Headlines
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/22/2024
Next Earnings (Confirmed)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:AVAH
Fax
N/A
Employees
33,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.80
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
-20.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
6 Analysts

Profitability

Net Income
$-134,520,000.00
Pretax Margin
-7.33%

Debt

Sales & Book Value

Annual Sales
$1.90 billion
Cash Flow
$0.57 per share
Book Value
($0.68) per share

Miscellaneous

Free Float
177,373,000
Market Cap
$436.70 million
Optionable
Optionable
Beta
2.03
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Rodney D. Windley (Age 76)
    Executive Chairman
    Comp: $120.5k
  • Mr. Jeffrey S. Shaner (Age 51)
    CEO & Director
    Comp: $1.1M
  • Mr. Ed Reisz (Age 65)
    Chief Administrative Officer
    Comp: $649.39k
  • Mr. Matthew Buckhalter (Age 35)
    CFO & Principal Financial Officer
  • Ms. Deborah Stewart (Age 40)
    Senior VP & Principal Accounting Officer
  • Mr. Patrick A. Cunningham (Age 68)
    Chief Compliance Officer
  • Ms. Korey Hinz
    President of Medical Solutions
  • Ms. Kristy Rohwedder
    President of Private Duty Nursing
  • Mr. Shane Brinkerhoff
    President of Home Health & Hospice
  • Ms. Rachel Witt
    Chief Clinical Officer

AVAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" AVAH shares.
View AVAH analyst ratings
or view top-rated stocks.

What is Aveanna Healthcare's stock price target for 2024?

6 Wall Street research analysts have issued twelve-month target prices for Aveanna Healthcare's stock. Their AVAH share price targets range from $1.00 to $3.00. On average, they anticipate the company's stock price to reach $1.80 in the next year. This suggests that the stock has a possible downside of 20.7%.
View analysts price targets for AVAH
or view top-rated stocks among Wall Street analysts.

How have AVAH shares performed in 2024?

Aveanna Healthcare's stock was trading at $2.68 on January 1st, 2024. Since then, AVAH shares have decreased by 15.3% and is now trading at $2.27.
View the best growth stocks for 2024 here
.

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AVAH earnings forecast
.

How can I listen to Aveanna Healthcare's earnings call?

Aveanna Healthcare will be holding an earnings conference call on Thursday, May 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13745298".

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings results on Thursday, March, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02. The company earned $478.84 million during the quarter, compared to analyst estimates of $464.33 million.

What guidance has Aveanna Healthcare issued on next quarter's earnings?

Aveanna Healthcare issued an update on its FY 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.

When did Aveanna Healthcare IPO?

Aveanna Healthcare (AVAH) raised $478 million in an IPO on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVAH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners